Author Archives: Natalie Themm
Early-Phase Data Support Novel Contrast Agent
ASE 2026 data support further development of MVT-100 in pivotal trials.
bioMérieux Seeks FDA Authorization for Point-of-Care Vaginitis Test
The automated PCR test provides results in 20 minutes to help clinicians diagnose common causes of vaginitis during a patient visit.
NUSANO COMPLETES MAJOR MILESTONE TOWARD COMMERCIAL RADIOISOTOPE PRODUCTION
FIRST OF THREE STEPS TOWARD BRINGING NOVEL RADIOISOTOPE PRODUCTION PLATFORM ONLINE
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
Novel gel embolic designed to give physicians greater control and consistency during embolization.
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SINTX’s advanced ceramic manufacturing platform supports customers across multiple industries requiring high-performance materials.
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Canary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth Visit
AI-powered voice analysis is now available to clinicians directly inside Zoom, transforming routine telehealth conversations into early signals for behavioral and cognitive health
Halia Therapeutics Secures FDA Fast Track for Ofirnoflast
The designation follows encouraging Phase 2 clinical trial results.
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer.
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs.
